fda glp-1 enforcement news today Harnessing Receptor Agonists for Obesity Treatment: Prospects and Obstacles on the Horizon FDA issues 30 warning letters

Take progress photos and measurements of waist, hips, chest, and limbs

Microdosing is off-label

While there have been improvements in survival over the last decade, progress has been incremental and the mortality rate remains the highest amongst solid malignancies (5-year survival rate of 13%) 2

Our virtual consultations allow you to meet with our team from anywhere in Nebraska

Results show that GLP-1RA users, defined as individuals with a history of use exceeding six months and with at least two refills within six months prior to the procedure, experienced a higher incidence rate of aspiration pneumonia (0.83%) compared to nonusers (0.63%), corresponding to a hazard ratio of 1.33